Alibaba Health Informatio... (ALBBY)
Alibaba Health Information Technology Statistics
Share Statistics
Alibaba Health Information Technology has 804.02M shares outstanding. The number of shares has increased by 964.57% in one year.
| Shares Outstanding | 804.02M |
| Shares Change (YoY) | 964.57% |
| Shares Change (QoQ) | 893.05% |
| Owned by Institutions (%) | n/a |
| Shares Floating | 5.46B |
| Failed to Deliver (FTD) Shares | 875 |
| FTD / Avg. Volume | 74.15% |
Short Selling Information
| Short Interest | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Valuation Ratios
The PE ratio is 45.38 and the forward PE ratio is null. Alibaba Health Information Technology's PEG ratio is 0.77.
| PE Ratio | 45.38 |
| Forward PE | n/a |
| PS Ratio | 1.48 |
| Forward PS | n/a |
| PB Ratio | 2.76 |
| P/FCF Ratio | 37.92 |
| PEG Ratio | 0.77 |
Enterprise Valuation
Alibaba Health Information Technology has an Enterprise Value (EV) of 792.3B.
| EV / Sales | 29.32 |
| EV / EBITDA | 793.05 |
| EV / EBIT | 733.72 |
| EV / FCF | 749.53 |
Financial Position
The company has a current ratio of 2.69, with a Debt / Equity ratio of 0.01.
| Current Ratio | 2.69 |
| Quick Ratio | 2.41 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | 0.08 |
| Debt / FCF | 0.08 |
| Interest Coverage | 146.16 |
Financial Efficiency
Return on Equity is 6.07% and Return on Invested Capital is 5.57%.
| Return on Equity | 6.07% |
| Return on Assets | 4.48% |
| Return on Invested Capital | 5.57% |
| Revenue Per Employee | $19.01M |
| Profits Per Employee | $621.29K |
| Employee Count | 1,422 |
| Asset Turnover | 1.37 |
| Inventory Turnover | 15.1 |
Taxes
| Income Tax | 56.26M |
| Effective Tax Rate | 5.99% |
Stock Price Statistics
The stock price has increased by 67.05% in the last 52 weeks. The beta is 1.58, so Alibaba Health Information Technology's price volatility has been higher than the market average.
| Beta | 1.58 |
| 52-Week Price Change | 67.05% |
| 50-Day Moving Average | 12.94 |
| 200-Day Moving Average | 10.15 |
| Relative Strength Index (RSI) | 46.44 |
| Average Volume (20 Days) | 1.18K |
Income Statement
In the last 12 months, Alibaba Health Information Technology had revenue of 27.03B and earned 883.48M in profits. Earnings per share was 1.25.
| Revenue | 27.03B |
| Gross Profit | 5.9B |
| Operating Income | 872.4M |
| Net Income | 883.48M |
| EBITDA | 999.05M |
| EBIT | 945.37M |
| Earnings Per Share (EPS) | 1.25 |
Balance Sheet
The company has 9.55B in cash and 82.17M in debt, giving a net cash position of 9.47B.
| Cash & Cash Equivalents | 9.55B |
| Total Debt | 82.17M |
| Net Cash | 9.47B |
| Retained Earnings | -11.97M |
| Total Assets | 19.71B |
| Working Capital | 8.49B |
Cash Flow
In the last 12 months, operating cash flow was 1.08B and capital expenditures -22.78M, giving a free cash flow of 1.06B.
| Operating Cash Flow | 1.08B |
| Capital Expenditures | -22.78M |
| Free Cash Flow | 1.06B |
| FCF Per Share | 0.08 |
Margins
Gross margin is 21.81%, with operating and profit margins of 3.23% and 3.27%.
| Gross Margin | 21.81% |
| Operating Margin | 3.23% |
| Pretax Margin | 3.48% |
| Profit Margin | 3.27% |
| EBITDA Margin | 3.7% |
| EBIT Margin | 3.23% |
| FCF Margin | 3.91% |
Dividends & Yields
ALBBY does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | 2.2% |
| FCF Yield | 0.13% |
Analyst Forecast
Currently there are no analyst rating for ALBBY.
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
Scores
| Altman Z-Score | 4.41 |
| Piotroski F-Score | 5 |